4d Molecular Therapeutics, Inc.
FDMT
Revenue
90.00k
▲75.00k▲500.00%
3 Months ChangeAssets
423.98M
▼-49.66M▼-10.48%
3 Months ChangeLiabilities
55.00M
▲2.25M▲4.27%
3 Months ChangeFree Cash Flow
-48.39M
▼-18.59M▼-62.39%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-01-26
Form 8-K
ID: 0001193125-26-022559
2026-01-07
Form 8-K
ID: 0001193125-26-005470
2025-12-10
Form 8-K
ID: 0001193125-25-314167
2025-11-17
Form 8-K
ID: 0001193125-25-283861
2025-11-10
Form 10-Q
ID: 0001193125-25-273343
2025-11-10
Form 8-K
ID: 0001193125-25-273340
2025-11-07
Form 8-K
ID: 0001193125-25-272286
2025-11-06
Form 8-K
ID: 0001193125-25-267934
2025-10-31
Form 8-K
ID: 0001193125-25-259302
2025-10-02
Form 8-K
ID: 0001193125-25-228289